ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,460, issued on Dec. 16, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Anti-MSR1 antibodies and methods of use thereof" was invented by Jesper Gromada (Concord, Mass.), Viktoria Gusarova (Pleasantville, N.Y.), Amy Han (Hockessin, Del.), Sokol Haxhinasto (Brookfield, Conn.), Christos Kyratsous (Irvington, N.Y.), Andrew J. Murphy (Croton-on Hudson, N.Y.), Thomas Nittoli (Pearl River, N.Y.), William Olson (Yorktown Heights, N.Y.), Matthew Sleeman (White Plains, N.Y.) and Anna Zumsteg (Elmsford, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies and antigen-binding fragments that bind MSR1 and methods ...